Cargando…
Structure of tyrosine aminotransferase from Leishmania infantum
The trypanosomatid parasite Leishmania infantum is the causative agent of visceral leishmaniasis (VL), which is usually fatal unless treated. VL has an incidence of 0.5 million cases every year and is an important opportunistic co-infection in HIV/AIDS. Tyrosine aminotransferase (TAT) has an importa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014323/ https://www.ncbi.nlm.nih.gov/pubmed/24817714 http://dx.doi.org/10.1107/S2053230X14007845 |
_version_ | 1782315154903400448 |
---|---|
author | Moreno, M. A. Abramov, A. Abendroth, J. Alonso, A. Zhang, S. Alcolea, P. J. Edwards, T. Lorimer, D. Myler, P. J. Larraga, V. |
author_facet | Moreno, M. A. Abramov, A. Abendroth, J. Alonso, A. Zhang, S. Alcolea, P. J. Edwards, T. Lorimer, D. Myler, P. J. Larraga, V. |
author_sort | Moreno, M. A. |
collection | PubMed |
description | The trypanosomatid parasite Leishmania infantum is the causative agent of visceral leishmaniasis (VL), which is usually fatal unless treated. VL has an incidence of 0.5 million cases every year and is an important opportunistic co-infection in HIV/AIDS. Tyrosine aminotransferase (TAT) has an important role in the metabolism of trypanosomatids, catalyzing the first step in the degradation pathway of aromatic amino acids, which are ultimately converted into their corresponding l-2-oxoacids. Unlike the enzyme in Trypanosoma cruzi and mammals, L. infantum TAT (LiTAT) is not able to transaminate ketoglutarate. Here, the structure of LiTAT at 2.35 Å resolution is reported, and it is confirmed that the presence of two Leishmania-specific residues (Gln55 and Asn58) explains, at least in part, this specific reactivity. The difference in substrate specificity between leishmanial and mammalian TAT and the importance of this enzyme in parasite metabolism suggest that it may be a useful target in the development of new drugs against leishmaniasis. |
format | Online Article Text |
id | pubmed-4014323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-40143232014-06-05 Structure of tyrosine aminotransferase from Leishmania infantum Moreno, M. A. Abramov, A. Abendroth, J. Alonso, A. Zhang, S. Alcolea, P. J. Edwards, T. Lorimer, D. Myler, P. J. Larraga, V. Acta Crystallogr F Struct Biol Commun Structural Communications The trypanosomatid parasite Leishmania infantum is the causative agent of visceral leishmaniasis (VL), which is usually fatal unless treated. VL has an incidence of 0.5 million cases every year and is an important opportunistic co-infection in HIV/AIDS. Tyrosine aminotransferase (TAT) has an important role in the metabolism of trypanosomatids, catalyzing the first step in the degradation pathway of aromatic amino acids, which are ultimately converted into their corresponding l-2-oxoacids. Unlike the enzyme in Trypanosoma cruzi and mammals, L. infantum TAT (LiTAT) is not able to transaminate ketoglutarate. Here, the structure of LiTAT at 2.35 Å resolution is reported, and it is confirmed that the presence of two Leishmania-specific residues (Gln55 and Asn58) explains, at least in part, this specific reactivity. The difference in substrate specificity between leishmanial and mammalian TAT and the importance of this enzyme in parasite metabolism suggest that it may be a useful target in the development of new drugs against leishmaniasis. International Union of Crystallography 2014-04-25 /pmc/articles/PMC4014323/ /pubmed/24817714 http://dx.doi.org/10.1107/S2053230X14007845 Text en © Moreno et al. 2014 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Structural Communications Moreno, M. A. Abramov, A. Abendroth, J. Alonso, A. Zhang, S. Alcolea, P. J. Edwards, T. Lorimer, D. Myler, P. J. Larraga, V. Structure of tyrosine aminotransferase from Leishmania infantum |
title | Structure of tyrosine aminotransferase from Leishmania infantum
|
title_full | Structure of tyrosine aminotransferase from Leishmania infantum
|
title_fullStr | Structure of tyrosine aminotransferase from Leishmania infantum
|
title_full_unstemmed | Structure of tyrosine aminotransferase from Leishmania infantum
|
title_short | Structure of tyrosine aminotransferase from Leishmania infantum
|
title_sort | structure of tyrosine aminotransferase from leishmania infantum |
topic | Structural Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014323/ https://www.ncbi.nlm.nih.gov/pubmed/24817714 http://dx.doi.org/10.1107/S2053230X14007845 |
work_keys_str_mv | AT morenoma structureoftyrosineaminotransferasefromleishmaniainfantum AT abramova structureoftyrosineaminotransferasefromleishmaniainfantum AT abendrothj structureoftyrosineaminotransferasefromleishmaniainfantum AT alonsoa structureoftyrosineaminotransferasefromleishmaniainfantum AT zhangs structureoftyrosineaminotransferasefromleishmaniainfantum AT alcoleapj structureoftyrosineaminotransferasefromleishmaniainfantum AT edwardst structureoftyrosineaminotransferasefromleishmaniainfantum AT lorimerd structureoftyrosineaminotransferasefromleishmaniainfantum AT mylerpj structureoftyrosineaminotransferasefromleishmaniainfantum AT larragav structureoftyrosineaminotransferasefromleishmaniainfantum |